Table of Contents
Journal of Hormones
Volume 2014, Article ID 190347, 17 pages
http://dx.doi.org/10.1155/2014/190347
Review Article

Systematic Literature Review of the Epidemiology of Nongenetic Forms of Hypogonadism in Adult Males

1Product Value Strategy Consulting, Optum, Eden Prairie, MN 55344, USA
2Global Health Outcomes, Merck & Co., Inc., West Point, PA 19486, USA
3School of Pharmacy, Temple University, Philadelphia, PA 19140, USA
4Epidemiology, Optum, Ann Arbor, MI 48108, USA
5Men’s Health Boston, Brookline, MA 02445, USA
6Harvard Medical School, Boston, MA 02115, USA
7Boolean Research Consulting, Westmount, QC, Canada
8Robert Hague Centre for Diabetes and Endocrinology, Barnsley Hospital NHS Foundation Trust, Barnsley S752EP, UK
9Department of Human Metabolism, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield S10 2RX, UK

Received 20 May 2014; Accepted 23 June 2014; Published 22 July 2014

Academic Editor: Jack van Honk

Copyright © 2014 Victoria Zarotsky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Bhasin, G. R. Cunningham, F. J. Hayes et al., “Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 6, pp. 2536–2559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. B. Araujo, A. B. O'Donnell, D. J. Brambilla et al., “Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts male aging study,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 5920–5926, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. Araujo, G. R. Esche, V. Kupelian et al., “Prevalence of symptomatic androgen deficiency in men,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4241–4247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Tajar, I. T. Huhtaniemi, T. W. O'Neill et al., “Characteristics of androgen deficiency in Late-onset hypogonadism: results from the European Male Aging study (EMAS),” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 5, pp. 1508–1516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Haring, T. Ittermann, H. Völzke et al., “Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania,” Aging Male, vol. 13, no. 4, pp. 247–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Ponholzer, S. Madersbacher, M. Rauchenwald, S. Jungwirth, P. Fischer, and K. Tragl, “Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: results of the VITA study,” World Journal of Urology, vol. 28, no. 2, pp. 209–214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Khoo, H. M. Tan, and W. Y. Low, “Erectile dysfunction and comorbidities in aging men: an urban cross-sectional study in Malaysia,” Journal of Sexual Medicine, vol. 5, no. 12, pp. 2925–2934, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Y. S. Wong, D. C. C. Chan, A. Hong, and J. Woo, “Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong,” Metabolism: Clinical and Experimental, vol. 55, no. 11, pp. 1488–1494, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Blümel, P. Chedraui, S. A. Gili, A. Navarro, K. Valenzuela, and S. Vallejo, “Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?” Maturitas, vol. 63, no. 4, pp. 365–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. L. di Luigi, P. Sgrò, V. Fierro et al., “Prevalence of undiagnosed testosterone deficiency in aging athletes: does exercise training influence the symptoms of male hypogonadism?” Journal of Sexual Medicine, vol. 7, no. 7, pp. 2591–2601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Goel, R. J. Sinha, D. Dalela, S. Sankhwar, and V. Singh, “Andropause in Indian men a preliminary cross-sectional study,” Urology Journal, vol. 6, no. 1, pp. 40–46, 2009. View at Google Scholar · View at Scopus
  12. C.-C. Liu, W.-J. Wu, Y.-C. Lee et al., “The prevalence of and risk factors for androgen deficiency in aging Taiwanese men,” Journal of Sexual Medicine, vol. 6, no. 4, pp. 936–946, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Mulligan, M. F. Frick, Q. C. Zuraw, A. Stemhagen, and C. McWhirter, “Prevalence of hypogonadism in males aged at least 45 years: The HIM study,” International Journal of Clinical Practice, vol. 60, no. 7, pp. 762–769, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. N. Júnior, S. dos Santos Szelbracikowski, A. C. Nardi, and J. C. de Almeida, “Age-related testosterone decline in a Brazilian cohort of healthy military men,” International Brazilian Journal of Urology, vol. 37, no. 5, pp. 591–597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H. J. Schneider, C. Sievers, J. Klotsche et al., “Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study,” Clinical Endocrinology, vol. 70, no. 3, pp. 446–454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Di Luigi, P. Sgrò, V. Fierro et al., “Prevalence of undiagnosed testosterone deficiency in aging athletes: does exercise training influence the symptoms of male hypogonadism?” Journal of Sexual Medicine, vol. 7, no. 7, pp. 2591–2601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Harman, E. J. Metter, J. D. Tobin, J. Pearson, and M. R. Blackman, “Longitudinal effects of aging on serum total and free testosterone levels in healthy men,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 2, pp. 724–731, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-Y. Li, X.-Y. Li, M. Li et al., “Decline of serum levels of free testosterone in aging healthy Chinese men,” Aging Male, vol. 8, no. 3-4, pp. 203–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. F. C. W. Wu, A. Tajar, J. M. Beynon et al., “Identification of late-onset hypogonadism in middle-aged and elderly men,” The New England Journal of Medicine, vol. 363, no. 2, pp. 123–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Abbasi, D. E. Mattson, M. Cuisinier et al., “Hyposomatomedinemia and hypogonadism in hemiplegic men who live in nursing homes,” Archives of Physical Medicine and Rehabilitation, vol. 75, no. 5, pp. 594–599, 1994. View at Google Scholar · View at Scopus
  21. F. Albaaj, M. Sivalingham, P. Haynes et al., “Prevalence of hypogonadism in male patients with renal failure,” Postgraduate Medical Journal, vol. 82, no. 972, pp. 693–696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. A. Allan, B. J. Strauss, H. G. Burger, E. A. Forbes, and R. I. McLachlan, “The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men,” Medical Journal of Australia, vol. 185, no. 8, pp. 424–427, 2006. View at Google Scholar · View at Scopus
  23. S. G. Anderson, A. Heald, N. Younger et al., “Screening for hypogonadism in diabetes 2008/9: results from the Cheshire Primary Care cohort,” Primary Care Diabetes, vol. 6, no. 2, pp. 143–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Arafa, W. Zohdy, S. Aboulsoud, and R. Shamloul, “Prevalence of late-onset hypogonadism in men with type 2 diabetes mellitus,” Andrologia, vol. 44, no. 1, pp. 756–763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Biswas, D. Hampton, R. G. Newcombe, and D. A. Rees, “Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life,” Clinical Endocrinology, vol. 76, no. 5, pp. 665–673, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. J. Bunch, D. Abraham, S. Wang, and A. W. Meikle, “Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction,” Aging Male, vol. 5, no. 1, pp. 38–46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. D. A. Caldas, A. L. Porto, L. D. C. D. Motta, and L. A. Casulari, “Relationship between insulin and hypogonadism in men with metabolic syndrome,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 53, no. 8, pp. 1005–1011, 2009. View at Google Scholar · View at Scopus
  28. J. J. Carrero, A. R. Qureshi, A. Nakashima et al., “Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease,” Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 184–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Y. T. Chen, G. A. Wittert, and G. R. Andrews, “Relative androgen deficiency in relation to obesity and metabolic status in older men,” Diabetes, Obesity and Metabolism, vol. 8, no. 4, pp. 429–435, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Clapauch, D. J. D. C. Braga, L. P. Marinheiro, S. Buksman, and Y. Schrank, “Risk of late-onset hypogonadism (Andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 52, no. 9, pp. 1439–1447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Collazos and M. Esteban, “Has prolactin a role in the hypogonadal status of HIV-infected patients?” Journal of the International Association of Physicians in AIDS Care, vol. 8, no. 1, pp. 43–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Corona, V. Boddi, F. Lotti et al., “The Relationship of testosterone to prostate-specific antigen in men with sexual dysfunction,” Journal of Sexual Medicine, vol. 7, no. 1, part 1, pp. 284–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Corona, E. Mannucci, F. Lotti et al., “Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism,” Journal of Sexual Medicine, vol. 6, no. 9, pp. 2591–2600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Corona, E. Mannucci, F. Lotti et al., “Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED,” Journal of Sexual Medicine, vol. 6, no. 1, pp. 285–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Corona, E. Mannucci, L. Petrone et al., “NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction,” Journal of Sexual Medicine, vol. 4, no. 4, part 1, pp. 1038–1045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Corona, E. Mannucci, L. Petrone et al., “Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic,” International Journal of Impotence Research, vol. 18, no. 2, pp. 190–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Corona, M. Monami, V. Boddi et al., “Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction,” Journal of Sexual Medicine, vol. 7, no. 4, pp. 1557–1564, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. N. F. Crum-Cianflone, M. Bavaro, B. Hale et al., “Erectile dysfunction and hypogonadism among men with HIV,” AIDS Patient Care and STDs, vol. 21, no. 1, pp. 9–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Dhindsa, M. G. Miller, C. L. McWhirter et al., “Testosterone concentrations in diabetic and nondiabetic obese men,” Diabetes Care, vol. 33, no. 6, pp. 1186–1192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Dhindsa, S. Prabhakar, M. Sethi, A. Bandyopadhyay, A. Chaudhuri, and P. Dandona, “Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5462–5468, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Durga, F. Sepahpanah, M. Regozzi, J. Hastings, and D. A. Crane, “Prevalence of testosterone deficiency after spinal cord injury,” PM & R, vol. 3, no. 10, pp. 929–932, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. H. A. Fink, S. K. Ewing, K. E. Ensrud et al., “Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 3908–3915, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. B. Fleishman, H. Khan, P. Homel et al., “Testosterone levels and quality of life in diverse male patients with cancers unrelated to androgens,” Journal of Clinical Oncology, vol. 28, no. 34, pp. 5054–5060, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Florvaag, V. Oberle, M. Fritzenwanger et al., “Testosterone deficiency in male heart failure patients and its effect on endothelial progenitor cells,” Aging Male, vol. 15, no. 3, pp. 180–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. H. K. Ganesh, H. A. V. Sarathi, J. George et al., “Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group,” Endocrine Practice, vol. 15, no. 6, pp. 513–520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. D. M. Greenfield, S. J. Walters, R. E. Coleman et al., “Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 9, pp. 3476–3482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Grossmann, S. Panagiotopolous, K. Sharpe et al., “Low testosterone and anaemia in men with type 2 diabetes,” Clinical Endocrinology, vol. 70, no. 4, pp. 547–553, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Grossmann, M. C. Thomas, S. Panagiotopoulos et al., “Low testosterone levels are common and associated with insulin resistance in men with diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1834–1840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Guay, A. D. Seftel, and A. Traish, “Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses,” International Journal of Impotence Research, vol. 22, no. 1, pp. 9–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. G. I. Hackett, N. S. Cole, A. A. Deshpande, M. D. Popple, D. Kennedy, and P. Wilkinson, “Biochemical hypogonadism in men with type 2 diabetes in primary care practice,” British Journal of Diabetes and Vascular Disease, vol. 9, no. 5, pp. 226–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Halabi, E. G. Collins, N. Thorevska, M. J. Tobin, and F. Laghi, “Relationship between depressive symptoms and hypogonadism in men with COPD,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 8, no. 5, pp. 346–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. A. Hamidi, A. Heidarzadeh, P. N. Akbari, D. F. Khosravi, and M. Z. Hamidi, “A survey on relative frequency of metabolic syndrome and testosterone deficiency in men with erectile dysfunction,” International Urology and Nephrology, vol. 44, no. 3, pp. 667–672, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Hintikka, L. Niskanen, H. Koivumaa-Honkanen et al., “Hypogonadism, decreased sexual desire, and long-term depression in middle-aged men,” Journal of Sexual Medicine, vol. 6, no. 7, pp. 2049–2057, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Hofstra, S. Loves, B. van Wageningen, J. Ruinemans-Koerts, I. Janssen, and H. de Boer, “High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment,” Netherlands Journal of Medicine, vol. 66, no. 3, pp. 103–109, 2008. View at Google Scholar · View at Scopus
  55. E. A. Jankowska, B. Biel, J. Majda et al., “Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival,” Circulation, vol. 114, no. 17, pp. 1829–1837, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Kapoor, H. Aldred, S. Clark, K. S. Channer, and T. H. Jones, “Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: Correlations with bioavailable testosterone and visceral adiposity,” Diabetes Care, vol. 30, no. 4, pp. 911–917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Kirbas, A. Abakay, F. Topcu, A. Kaplan, M. Unlu, and Y. Peker, “Obstructive sleep apnoea, cigarette smoking and serum testosterone levels in a male sleep clinic cohort,” Journal of International Medical Research, vol. 35, no. 1, pp. 38–45, 2007. View at Google Scholar
  58. R. S. Klein, Y. Lo, N. Santoro, and A. S. Dobs, “Androgen levels in older men who have or who are at risk of acquiring HIV infection,” Clinical Infectious Diseases, vol. 41, no. 12, pp. 1794–1803, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. T. S. Köhler, J. Kim, K. Feia et al., “Prevalence of androgen deficiency in men with erectile dysfunction,” Urology, vol. 71, no. 4, pp. 693–697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Kyriazis, I. Tzanakis, K. Stylianou et al., “Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 26, no. 9, pp. 2971–2977, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. S. la Vignera, A. E. Calogero, R. Condorelli, F. Lanzafame, B. Giammusso, and E. Vicari, “Andrological characterization of the patient with diabetes mellitus,” Minerva Endocrinologica, vol. 34, no. 1, pp. 1–9, 2009. View at Google Scholar · View at Scopus
  62. D. E. Laaksonen, L. Niskanen, K. Punnonen et al., “The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 2, pp. 712–719, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. J. E. Lackner, I. Märk, G. Schatzl, M. Marberger, and C. Kratzik, “Hypogonadism and androgen deficiency symptoms in testicular cancer survivors,” Urology, vol. 69, no. 4, pp. 754–758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. F. Laghi, A. Antonescu-Turcu, E. Collins et al., “Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life,” The American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 7, pp. 728–733, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Lerchbaum, S. Pilz, B. O. Boehm, T. B. Grammer, B. Obermayer-Pietsch, and W. März, “Combination of low free testosterone and low vitamin D predicts mortality in older men referred for coronary angiography,” Clinical Endocrinology, vol. 77, no. 3, pp. 475–483, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. A. A. Makhlouf, M. A. Mohamed, A. D. Seftel, and C. Neiderberger, “Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction,” International Journal of Impotence Research, vol. 20, no. 2, pp. 157–161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. C. J. Malkin, P. J. Pugh, P. D. Morris, S. Asif, T. H. Jones, and K. S. Channer, “Low serum testosterone and increased mortality in men with coronary heart disease,” Heart, vol. 96, no. 22, pp. 1821–1825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. R. S. McIntyre, D. Mancini, B. S. Eisfeld et al., “Calculated bioavailable testosterone levels and depression in middle-aged men,” Psychoneuroendocrinology, vol. 31, no. 9, pp. 1029–1035, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. S. A. Moreno and A. Morgentaler, “Testosterone deficiency and Peyronie's disease: pilot data suggesting a significant relationship,” Journal of Sexual Medicine, vol. 6, no. 6, pp. 1729–1735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. A. O. Ogbera, “Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus,” West African Journal of Medicine, vol. 30, no. 4, pp. 277–281, 2011. View at Google Scholar · View at Scopus
  71. O. A. Ogbera, C. Sonny, F. Olufemi, and A. Wale, “Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus,” Journal of the College of Physicians and Surgeons Pakistan, vol. 21, no. 9, pp. 517–521, 2011. View at Google Scholar · View at Scopus
  72. M. S. Okun, M. R. DeLong, J. Hanfelt, M. Gearing, and A. Levey, “Plasma testosterone levels in Alzheimer and Parkinson diseases,” Neurology, vol. 62, no. 3, pp. 411–413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. M. S. Okun, W. M. McDonald, and M. R. Delong, “Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity,” Archives of Neurology, vol. 59, no. 5, pp. 807–811, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Pellitero, I. Olaizola, A. Alastrue et al., “Hypogonadotropic hypogonadism in morbidly obese males is reversed after bariatric surgery,” Obesity Surgery, vol. 22, no. 12, pp. 1835–1842, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Pühse, A. Secker, S. Kemper, L. Hertle, and S. Kliesch, “Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment,” International Journal of Andrology, vol. 34, no. 5, part 2, pp. e351–e357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Rajagopal, R. Vassilopoulou-Sellin, J. L. Palmer, G. Kaur, and E. Bruera, “Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids,” Cancer, vol. 100, no. 4, pp. 851–858, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. E. L. Rhoden, E. P. Ribeiro, C. Teloken, and C. A. V. Souto, “Diabetes mellitus is associated with subnormal serum levels of free testosterone in men,” BJU International, vol. 96, no. 6, pp. 867–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Rietschel, C. Corcoran, T. Stanley, N. Basgoz, A. Klibanski, and S. Grinspoon, “Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy,” Clinical Infectious Diseases, vol. 31, no. 5, pp. 1240–1244, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Romerius, O. Ståhl, C. Moëll et al., “Hypogonadism risk in men treated for childhood cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 11, pp. 4180–4186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Salonia, A. Gallina, A. Briganti et al., “Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy,” Cancer, vol. 117, no. 17, pp. 3953–3962, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. G. Schatzl, C. Brössner, S. Schmid et al., “Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function,” Urology, vol. 55, no. 3, pp. 397–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Schatzl, S. Madersbacher, T. Thurridl et al., “High-grade prostate cancer is associated with low serum testosterone levels,” Prostate, vol. 47, no. 1, pp. 52–58, 2001. View at Publisher · View at Google Scholar · View at Scopus
  83. S. K. Singh, R. Goyal, and D. D. Pratyush, “Is hypoandrogenemia a component of metabolic syndrome in males?” Experimental and Clinical Endocrinology & Diabetes, vol. 119, no. 1, pp. 30–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. E. Serra, M. Porcu, L. Minerba et al., “High prevalence of male hypogonadism and sexual dysfunction in long-term clinically stable heart transplantation recipients,” International Journal of Cardiology, vol. 155, no. 3, pp. 476–477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. B. Somani, S. Khan, and R. Donat, “Screening for metabolic syndrome and testosterone deficiency in patients with erectile dysfunction: results from the first UK prospective study,” BJU International, vol. 106, no. 5, pp. 688–690, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Taddesse, I. L. Woldie, P. Khana et al., “Hypogonadism in patients with sickle cell disease: central or peripheral?” Acta Haematologica, vol. 128, no. 2, pp. 65–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. S. K. Talukder, F. Afsana, and S. J. Khan, “Metabolic syndrome in men with sexual dysfunction,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 4, no. 3, pp. 143–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. W. S. Tan, C. J. Ng, E. M. Khoo, W. Low, and H. M. Tan, “The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men's Health Study),” The Aging Male, vol. 14, no. 4, pp. 231–236, 2011. View at Google Scholar · View at Scopus
  89. B. Tengstrand, K. Carlström, and I. Hafström, “Bioavailable testosterone in men with rheumatoid arthritis—high frequency of hypogonadism,” Rheumatology, vol. 41, no. 3, pp. 285–289, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. T. G. Travison, R. Shackelton, A. B. Araujo et al., “The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission,” Journal of the American Geriatrics Society, vol. 56, no. 5, pp. 831–839, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Tromp, J. J. M. Claessens, S. L. Knijnenburg et al., “Reproductive status in adult male long-term survivors of childhood cancer,” Human Reproduction, vol. 26, no. 7, pp. 1775–1783, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. G. Wagner, J. G. Rabkin, and R. Rabkin, “Illness stage, concurrent medications, and other correlates of low testosterone in men with HIV illness,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 8, no. 2, pp. 204–207, 1995. View at Google Scholar · View at Scopus
  93. J. T. Wahlstrom, A. Tang, J. Cofrancesco, N. Shah Jr., and A. S. Dobs, “Gonadal hormone levels in injection drug users,” Drug and Alcohol Dependence, vol. 60, no. 3, pp. 311–313, 2000. View at Publisher · View at Google Scholar · View at Scopus
  94. X.-F. Wang, J.-H. Wang, and J.-Y. Li, “Androgen deficiency in elderly men with systolic chronic heart failure,” Journal of Geriatric Cardiology, vol. 7, no. 3-4, pp. 138–142, 2010. View at Google Scholar · View at Scopus
  95. E. Wehr, S. Pilz, B. O. Boehm, W. März, and B. Obermayer-Pietsch, “Association of vitamin D status with serum androgen levels in men,” Clinical Endocrinology, vol. 73, no. 2, pp. 243–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. D. M. Wunder, N. A. Bersinger, C. A. Fux et al., “Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy,” Antiviral Therapy, vol. 12, no. 2, pp. 261–265, 2007. View at Google Scholar · View at Scopus
  97. M. I. Yilmaz, A. Sonmez, A. R. Qureshi et al., “Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 7, pp. 1617–1625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. S. A. Hall, A. B. Araujo, G. R. Esche et al., “Treatment of symptomatic androgen deficiency: results from the Boston Area Community Health Survey,” Archives of Internal Medicine, vol. 168, no. 10, pp. 1070–1076, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. P. Dandona and M. T. Rosenberg, “A practical guide to male hypogonadism in the primary care setting,” International Journal of Clinical Practice, vol. 64, no. 6, pp. 682–696, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Fernández-Balsells, M. Murad, M. Lane et al., “Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2560–2575, 2010. View at Publisher · View at Google Scholar
  101. E. S. Orwoll, C. M. Nielson, F. Labrie et al., “Evidence for geographical and racial variation in serum sex steroid levels in older men,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 10, pp. E151–E160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Basaria, A. D. Coviello, T. G. Travison et al., “Adverse events associated with testosterone administration,” The New England Journal of Medicine, vol. 363, no. 2, pp. 109–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. U. Srinivas-Shankar, S. A. Roberts, M. J. Connolly et al., “Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 639–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. R. Vigen, C. O'Donnell, A. Barón et al., “Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels,” The Journal of the American Medical Association, vol. 310, no. 17, pp. 1829–1836, 2013. View at Google Scholar